How much funding has Docbot raised?

Docbot has raised $8.5M in total funding, most recently a Seed round.

Who are Docbot's investors?

Docbot's investors include Khosla Ventures, Y Combinator Continuity Fund, Bold Capital Partners, Collaborative Fund.

Where is Docbot headquartered?

Docbot is headquartered in Los Angeles, California, United States.

What industry is Docbot in?

Docbot operates in Healthcare, Artificial Intelligence, Biotech.

Docbot

Acquired

AI-powered image analysis for GI endoscopy diagnostics

Los Angeles, United States · Founded 2014 · $8.5M raised

Healthcare

Artificial Intelligence

Biotech

YC W19

Headquarters: Los Angeles, California
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: docbot.co
Total Funding: $8.5M
Last Round: $4.5M SeedMay 2021
Rounds: 2

About

AI technology company focused on gastrointestinal (GI) disease diagnosis using computer vision. Platform: UltivisionAI software for real-time image analysis, automated reporting, and analytic tools in endoscopy. Improves patient care and clinical workflows via AI-assisted image analysis in colonoscopy and GI procedures. Raised $4M Series A (Jun 2021) led by Khosla Ventures.

Summary

Docbot is a Healthcare company based in Los Angeles, United States, founded in 2014. It has raised $8.5M in total across 2 rounds, most recently a $4.5M Seed round in May 2021. Investors include Khosla Ventures, Y Combinator Continuity Fund and Bold Capital Partners.